Evidence map›Paper›PMID 26981786›Full record

ArticleEmerging infectious diseases2016

Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali.

Nafomon Sogoba, Kyle Rosenke, Jennifer Adjemian, Sory Ibrahim Diawara, Ousmane Maiga, Moussa Keita, Drissa Konaté, Abdoul Salam Keita, Ibrahim Sissoko, Matt Boisen and 9 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Seroprevalence of Arboviruses in a Malaria Hyperendemic Area in Southern Mali.The American journal of tropical medicine and hygiene · 2024
    Article
  7. Article
  8. Epidemiology of Lassa Fever.Current topics in microbiology and immunology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Ebola Virus IgG Seroprevalence in Southern Mali.Emerging infectious diseases · 2021
    Article
  15. The niche of One Health approaches in Lassa fever surveillance and control.Annals of clinical microbiology and antimicrobials · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Nafomon Sogoba
Kyle Rosenke
Jennifer Adjemian
Sory Ibrahim Diawara
Ousmane Maiga
Moussa Keita
Drissa Konaté
Abdoul Salam Keita
Ibrahim Sissoko
Matt Boisen
Diana Nelson
Darin Oottamasathien
Molly Millett
Robert F Garry
Luis M Branco
Sékou F Traoré
Seydou Doumbia
Heinz Feldmann
David Safronetz
Corgenix (United States) · USTulane University · USUniversité des Sciences, des Techniques et des Technologies de Bamako · MLPublic Health Agency of Canada · CAZalgen (United States) · USNational Institutes of Health · US

Funding

Viral Hemorrhagic Fevers: Disease Modeling and TransmissionZIAAI001089 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FELDMANN, HEINRICH · 2009 to 2025
$50.7M
Mali International Center for Excellence in ResearchZIAAI001189 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FELDMANN, HEINRICH · 2014 to 2025
$3.5M
Intramural NIH HHS
6 · The paper itself

Abstract

Lassa virus (LASV) is endemic to several nations in West Africa. In Mali, LASV was unknown until an exported case of Lassa fever was reported in 2009. Since that time, rodent surveys have found evidence of LASV-infected Mastomys natalensis rats in several communities in southern Mali, near the border with Côte d'Ivoire. Despite increased awareness, to date only a single case of Lassa fever has been confirmed in Mali. We conducted a survey to determine the prevalence of LASV exposure among persons in 3 villages in southern Mali where the presence of infected rodents has been documented. LASV IgG seroprevalence ranged from 14.5% to 44% per village. No sex bias was noted; however, seropositivity rates increased with participant age. These findings confirm human LASV exposure in Mali and suggest that LASV infection/Lassa fever is a potential public health concern in southern Mali.

Indexed as

AdolescentAdultAgedAged, 80 and overAnimalsAntibodies, ViralChildChild, PreschoolDisease ReservoirsFemaleHumansImmunoglobulin GInfantLassa FeverLassa virusMaleAntibodies, ViralImmunoglobulin Garenavirusemerging infectious diseasesLassa feverLassa virus seroprevalencesouthern Maliviral hemorrhagic fevervirusesWest Africazoonoses

Identifiers

PMID26981786
PMCPMC4806955
OpenAlexW2331158448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.